Regulators news from FierceBioResearcher

The argument over the FDA's role in regulating cancer therapies often comes down to one man: Dr. Richard Pazdur, a veteran oncologist and chief of the agency's oncology office. Patient groups and Read more...

Leaders in the nanotech field have been beating a path to Congress, asking lawmakers to significantly boost federal support of research into molecular-level advances. Currently, taxpayers fund about Read more...

The Boston Globe uses California's experience with its stem cell program as a cautionary tale as lawmakers debate a proposed bill that would provide a billion dollars to support the life sciences Read more...

Even as the demand for new antibiotics grows, new research programs to advance fresh therapies have been drying up fast. While existing antibiotics steadily weaken against the onslaught of some Read more...

Scientists in Singapore are advocating new rules that would permit researchers to splice human DNA into animals to further stem cell research. The development of human/animal chimeras would allow Read more...

A combo act featuring a slate of top European companies and clinical research organizations are bringing a close to an 80-year era of animal tests for acute toxicity. Since 1927 drug researchers have Read more...

More Research Lawmakers in the UK are scheduled to debate a controversial new law that would allow couples to create embryos derived from three parents. The procedure would require the nucleus of one Read more...

In the interest of making more and better human stem cells for research, U.K. regulators have approved the creation of short-lived human/animal hybrid embryos. Only tiny fragments of animal DNA will Read more...

Stem Cell Research

Researchers at Advanced Cell Technology has developed three new stem cell lines by taking an individual cell from an embryo and then froze the embryo with no harm done to it. ACT had generated a wave of criticism for its earlier announcement on the process. That work involved destroying the embryo to prove the theory that you could develop stem cell lines by withdrawing cells from an embryo. This new work saves the embryo to …

Read more...

The head of the National Institutes of Health has called on the White House to reverse its position limiting federal funding of embryonic stem cell research, calling it a shortsighted approach that has sidelined the NIH in an important field. Up until Elias Zerhouni's (photo) testimony to a Senate committee yesterday, he had been …

Read more...